Page last updated: 2024-12-07

nalidixate sodium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tris(hydroxymethyl)phosphine: coupling reagent for enzyme immobilization [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID76001
CHEMBL ID279546
SCHEMBL ID235349
MeSH IDM0014438

Synonyms (25)

Synonym
phosphinidynetrimethanol
phosphinidynetrismethanol
tris(methanol)phosphine
trimethylolphosphine
einecs 220-445-6
tris(hydroxymethyl)phosphine
methanol, phosphinidynetris-
tris(hydroxymethyl)phosphine, 90%
bis(hydroxymethyl)phosphanylmethanol
CHEMBL279546
methanol, 1,1',1''-phosphinidynetris-
unii-y6tg7wf7oq
2767-80-8
methanol, phosphinidynetri-
y6tg7wf7oq ,
SCHEMBL235349
tris hydroxymethyl phosphine
JMXMXKRNIYCNRV-UHFFFAOYSA-N
tris-hydroxymethylphosphine
DTXSID0062634
AKOS028108502
mfcd00055382
J-016853
BCP07227
Q27294320
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID317470Cytotoxicity against human Daudi cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
AID317468Cytotoxicity against human A549 cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
AID317469Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
AID317471Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
AID317472Cytotoxicity against human A375 cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
AID317467Cytotoxicity against human HL60 cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
AID317473Cytotoxicity against human CaCo2 cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
AID317478Cytotoxicity against human HeLa cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
AID317474Cytotoxicity against human HCT15 cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Feb-28, Volume: 51, Issue:4
In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.36 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]